https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT05233397&r=1
Tocilizumab for the Treatment of Progressive or Recurrent Pediatric Adamantinomatous...
Tocilizumab for the Treatment of Progressive or Recurrent Pediatric Adamantinomatous Craniopharyngioma
for thetocilizumabtreatmentprogressiverecurrent
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1362278/full
Frontiers | Ferroptosis-related biomarkers for adamantinomatous craniopharyngioma treatment:...
Adamantinomatous craniopharyngioma (ACP) is difficult to cure completely and prone to recurrence after surgery. Ferroptosis as an iron-dependent programmed c...
frontiersferroptosisrelatedbiomarkerscraniopharyngioma